The investigation into circulating angiotensin-converting enzyme (ACE) levels in patients newly diagnosed with chronic hepatitis B (CHB) seeks to elucidate the association between liver fibrosis and serum ACE concentrations. Here, ACE is linked to chronic hepatitis B virus infection.